Education
About Us
Working with TipRanks
Follow Us
Lincoln Pharmaceuticals Ltd (IN:LINCOLN)
:LINCOLN
LINCOLN Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹500.00 - ₹975.00
Previous CloseN/A
Volume57.32K
Average Volume (3M)3.69K
Market Cap
₹11.02B
Enterprise Value₹11.14B
Total Cash (Recent Filing)₹1.97B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)13.4
Beta1.53
Next Earnings
Aug 12, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 13, 2024Dividend Yield0.33%
Share Statistics
EPS (TTM)5.78
Shares Outstanding20,029,728
10 Day Avg. Volume3,147
30 Day Avg. Volume3,689
Financial Highlights & Ratios
PEG Ratio-1.75
Price to Book (P/B)1.68
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
LINCOLN FAQ
What was Lincoln Pharmaceuticals Ltd’s price range in the past 12 months?
Lincoln Pharmaceuticals Ltd lowest stock price was ₹500.00 and its highest was ₹975.00 in the past 12 months.
What is Lincoln Pharmaceuticals Ltd’s market cap?
Lincoln Pharmaceuticals Ltd’s market cap is ₹11.02B.
When is Lincoln Pharmaceuticals Ltd’s upcoming earnings report date?
Lincoln Pharmaceuticals Ltd’s upcoming earnings report date is Aug 12, 2025 which is in 29 days.
How were Lincoln Pharmaceuticals Ltd’s earnings last quarter?
Lincoln Pharmaceuticals Ltd released its earnings results on May 22, 2025. The company reported ₹5.78 earnings per share for the quarter, beating the consensus estimate of N/A by ₹5.78.
Is Lincoln Pharmaceuticals Ltd overvalued?
According to Wall Street analysts Lincoln Pharmaceuticals Ltd’s price is currently Overvalued.
Does Lincoln Pharmaceuticals Ltd pay dividends?
Lincoln Pharmaceuticals Ltd pays a Annually dividend of ₹1.799 which represents an annual dividend yield of 0.33%. See more information on Lincoln Pharmaceuticals Ltd dividends here
What is Lincoln Pharmaceuticals Ltd’s EPS estimate?
Lincoln Pharmaceuticals Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lincoln Pharmaceuticals Ltd have?
Lincoln Pharmaceuticals Ltd has 20,029,728 shares outstanding.
What happened to Lincoln Pharmaceuticals Ltd’s price movement after its last earnings report?
Lincoln Pharmaceuticals Ltd reported an EPS of ₹5.78 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -8.593%.
Which hedge fund is a major shareholder of Lincoln Pharmaceuticals Ltd?
Currently, no hedge funds are holding shares in IN:LINCOLN
Company Description
Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative. The company also offers branded generics. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.
Technical Analysis
Kilitch Drugs (India) Limited
―
Kopran Limited
―
Themis Medicare Limited
―
Wanbury Limited
―
Anuh Pharma Limited
―